On April 24, 2023 Vivesto AB, an oncology-focused R&D company, reported that the Annual Report for 2022 has been published. The Annual Report is attached as a PDF and is available on the company’s website, View Source (Press release, Vivesto, APR 25, 2023, View Source [SID1234630445]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

For further information:
Erik Kinnman, Chief Executive Officer
Phone: +46 18-50 54 40
E-mail: [email protected]